Paper Details

  1. Home
  2. Paper Details

World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.

Author: GotlibJason

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review discussed the diagnosis, risk stratification, and treatment of eosinophilia. The review highlights the importance of identifying the subtype of eosinophilia in order to choose the most appropriate treatment.
Paper Details　
Original Abstract of the Article :
DISEASE OVERVIEW: The eosinophilias encompass a broad range of non-hematologic (secondary or reactive) and hematologic (primary, clonal) disorders with potential for end-organ damage. DIAGNOSIS: Hypereosinophilia has generally been defined as a peripheral blood eosinophil count greater than 1,500/m...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/ajh.24196

データ提供：米国国立医学図書館（NLM）

Eosinophilic Disorders: A Comprehensive Update on Diagnosis, Risk Stratification, and Management

We're venturing into the intricate world of [hematology] and its diverse manifestations in [eosinophilic disorders]. This study provides a comprehensive overview of the latest guidelines for diagnosing, risk stratifying, and managing [eosinophilic disorders]. It's like navigating a vast and complex desert of blood diseases, seeking to understand the various paths these disorders can take.

Understanding the Complexity of Eosinophilic Disorders

The study highlights the importance of differentiating between [secondary (reactive)] and [primary (clonal)] eosinophilic disorders, as they have distinct causes and treatment strategies. The authors also emphasize the need for a multidisciplinary approach to diagnosis and management, involving hematologists, allergists, and other specialists.

Finding Effective Treatment Options for Eosinophilic Disorders

This study provides valuable guidance for clinicians treating patients with [eosinophilic disorders], offering a roadmap for diagnosis, risk stratification, and management. It's a reminder that the desert of hematological research is always evolving, and new approaches are constantly emerging to address these challenging conditions.

Dr. Camel's Conclusion

This study provides a comprehensive and up-to-date guide for understanding and managing [eosinophilic disorders]. It's a reminder that the desert of blood diseases can be challenging, but with the right knowledge and tools, we can navigate it effectively and find the best possible care for patients.
Date :
  1. Date Completed 2016-01-22
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

26486351

DOI: Digital Object Identifier

10.1002/ajh.24196

Related Literature

Article Analysis
・Causes of eosinophilic disorders
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.